Written by: Casey Hribrar | Last reviewed: May 2019
- FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65. PR Newswire. https://www.prnewswire.com/news-releases/fda-approves-the-reintroduction-of-zelnorm-tegaserod-for-irritable-bowel-syndrome-with-constipation-ibs-c-in-women-under-65-300821611.html. Published April 1, 2019. Accessed April 22, 2019.
- Zelnorm Prescribing Information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021200Orig1s015lbl.pdf. Published March 2019. Accessed April 2019.